beta-2-Thienyl-L-alanine
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- beta-2-Thienyl-L-alanine
- DrugBank Accession Number
- DB03673
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 171.217
Monoisotopic: 171.035399227 - Chemical Formula
- C7H9NO2S
- Synonyms
- beta-(2-Thienyl)-L-alanine
- L-3-(2-thienyl)alanine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UPhenylalanine-4-hydroxylase Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Amino acids, peptides, and analogues
- Direct Parent
- L-alpha-amino acids
- Alternative Parents
- Aralkylamines / Thiophenes / Heteroaromatic compounds / Amino acids / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives show 1 more
- Substituents
- Amine / Amino acid / Aralkylamine / Aromatic heteromonocyclic compound / Carbonyl group / Carboxylic acid / Heteroaromatic compound / Hydrocarbon derivative / L-alpha-amino acid / Monocarboxylic acid or derivatives show 10 more
- Molecular Framework
- Aromatic heteromonocyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 2EMW41BM77
- CAS number
- 22951-96-8
- InChI Key
- WTOFYLAWDLQMBZ-LURJTMIESA-N
- InChI
- InChI=1S/C7H9NO2S/c8-6(7(9)10)4-5-2-1-3-11-5/h1-3,6H,4,8H2,(H,9,10)/t6-/m0/s1
- IUPAC Name
- (2S)-2-amino-3-(thiophen-2-yl)propanoic acid
- SMILES
- N[C@@H](CC1=CC=CS1)C(O)=O
References
- General References
- Not Available
- External Links
- PubChem Compound
- 146719
- PubChem Substance
- 46504951
- ChemSpider
- 129413
- ChEMBL
- CHEMBL1236302
- ZINC
- ZINC000004141711
- PDBe Ligand
- TIH
- PDB Entries
- 1bdk / 1eoj / 1kw0 / 1mmk / 4oz6 / 4trw / 4try / 4trz / 5lht
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 1.61 mg/mL ALOGPS logP -1.8 ALOGPS logP -1.3 Chemaxon logS -2 ALOGPS pKa (Strongest Acidic) 2.6 Chemaxon pKa (Strongest Basic) 9.27 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 63.32 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 42.12 m3·mol-1 Chemaxon Polarizability 16.88 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.964 Blood Brain Barrier + 0.8286 Caco-2 permeable + 0.5145 P-glycoprotein substrate Non-substrate 0.6881 P-glycoprotein inhibitor I Non-inhibitor 0.9893 P-glycoprotein inhibitor II Non-inhibitor 0.9902 Renal organic cation transporter Non-inhibitor 0.9225 CYP450 2C9 substrate Non-substrate 0.772 CYP450 2D6 substrate Non-substrate 0.8128 CYP450 3A4 substrate Non-substrate 0.8201 CYP450 1A2 substrate Non-inhibitor 0.8866 CYP450 2C9 inhibitor Non-inhibitor 0.9244 CYP450 2D6 inhibitor Non-inhibitor 0.9638 CYP450 2C19 inhibitor Non-inhibitor 0.9211 CYP450 3A4 inhibitor Non-inhibitor 0.9606 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.951 Ames test Non AMES toxic 0.8124 Carcinogenicity Non-carcinogens 0.8789 Biodegradation Ready biodegradable 0.7437 Rat acute toxicity 2.0284 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9941 hERG inhibition (predictor II) Non-inhibitor 0.9659
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-004i-9500000000-c75a7f746e9604ab7c90 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0a6r-0900000000-a0439ec884181a37aabb Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-3900000000-903b127e771018ff7274 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-1900000000-8e76eea54eac5bf1166a Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-00di-9600000000-3d47dfdcf6ea3de3d902 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0ldj-9400000000-da713e2498f3644a76f5 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-001j-9000000000-db71165b12c4f8b0cf75 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 134.5419701 predictedDarkChem Lite v0.1.0 [M-H]- 129.9634 predictedDeepCCS 1.0 (2019) [M+H]+ 135.0558701 predictedDarkChem Lite v0.1.0 [M+H]+ 133.79076 predictedDeepCCS 1.0 (2019) [M+Na]+ 134.2301701 predictedDarkChem Lite v0.1.0 [M+Na]+ 142.94743 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsPhenylalanine-4-hydroxylase
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine
- Specific Function
- iron ion binding
- Gene Name
- PAH
- Uniprot ID
- P00439
- Uniprot Name
- Phenylalanine-4-hydroxylase
- Molecular Weight
- 51861.565 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52